A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells)

Background Tumor-infiltrating lymphocytes (TILs), part of the host immune response, have been widely reported as influential factors in the tumor microenvironment for the clinical outcome of colorectal cancer (CRC). However, the network of helper T cells is very complex, and which T-cell subtypes af...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of surgical oncology 2016-03, Vol.23 (3), p.919-927
Hauptverfasser: Yoshida, Naohiro, Kinugasa, Tetsushi, Miyoshi, Hiroaki, Sato, Kensaku, Yuge, Kotaro, Ohchi, Takafumi, Fujino, Shinya, Shiraiwa, Sachiko, Katagiri, Mitsuhiro, Akagi, Yoshito, Ohshima, Koichi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 927
container_issue 3
container_start_page 919
container_title Annals of surgical oncology
container_volume 23
creator Yoshida, Naohiro
Kinugasa, Tetsushi
Miyoshi, Hiroaki
Sato, Kensaku
Yuge, Kotaro
Ohchi, Takafumi
Fujino, Shinya
Shiraiwa, Sachiko
Katagiri, Mitsuhiro
Akagi, Yoshito
Ohshima, Koichi
description Background Tumor-infiltrating lymphocytes (TILs), part of the host immune response, have been widely reported as influential factors in the tumor microenvironment for the clinical outcome of colorectal cancer (CRC). However, the network of helper T cells is very complex, and which T-cell subtypes affect the progression of CRC and postoperative prognosis remains unclear. This study investigated the expression of several subtypes of TILs including T helper type 1 (Th1), Th2, Th17, and regulatory T (Treg) cells to determine their correlation with clinicopathologic features and postoperative prognosis. Methods The study investigated the expression of TILs using immunohistochemistry of tissue microarray samples for 199 CRC patients. The number of each T-cell subtype infiltrating tumors was counted using ImageJ software. The relationship between TIL marker expression, clinicopathologic features, and prognosis was analyzed. Results A high RORγT/CD3 ratio (Th17 ratio) was significantly correlated with lymph node metastasis ( p  = 0.002), and a high of Foxp3/CD3 ratio (Treg ratio) was correlated with tumor location in the colon ( p  = 0.04), as shown by the Chi square test. In multivariate analysis, a high RORγT/CD3 ratio was the only independent prognostic factor for overall survival ( p  = 0.04; hazard ratio [HR], 1.84; 95 % confidence interval [CI] 1.02–3.45). Conclusions This study confirmed a high RORγT/CD3 ratio as a strong prognostic marker for postoperative survival. The immunohistochemistry results suggest that Th17 may affect lymph node metastasis in CRC. If new immunotherapies reducing Th17 expression are established, they may improve the efficiency of cancer treatment and prolong the survival of patients with CRC.
doi_str_mv 10.1245/s10434-015-4923-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1773830452</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1764339945</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-7c6781db38d424acaf0e184eee8fbd9eaccac7c5b8eebd3013d026a48461f2883</originalsourceid><addsrcrecordid>eNqNkc1u1DAUhSMEakvLA7BBd9lKhPovicNuFCiDNFKraVhbjnOTSZWJBzsZKc_FmlfgmfBopixRF_7RyXeO7Zwoek_JJ8pEcuspEVzEhCaxyBmP-avogiZBEamkr8OepDLOWZqcR2-9fyKEZpwkZ9F5kFLBhLiIfi9g2bUbWN-v__wqb4svHNZ67Cx0HjQ8js4OLTw42w7Wj52BO21G66AJ4yEodocu4HuEx8ntu73uoRtgUe_1YLCGwvbWoRmDXBwU9xkWg-5nH9JtA0vsgx9KKLDvYTVvdxtr5hE9XJcb-hHKDTtMNAM91LDGdup1OH0-OfzNVfSm0b3Hd6f1Mvpx97UslvHq_tv3YrGKjRDZGGcmzSStKy7r8GptdEOQSoGIsqnqHLUx2mQmqSRiVXNCeU1YqoUUKW2YlPwyuj7m7pz9OaEf1bbzJlxBD2gnr2iWccmJSNgL0FRwnuciCSg9osZZ7x02aue6rXazokQdClbHglUoWB0KVjx4Ppzip2qL9T_Hc6MBYEfAh09Di0492cmFn-7_k_oX5cCxOw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1764339945</pqid></control><display><type>article</type><title>A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells)</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Yoshida, Naohiro ; Kinugasa, Tetsushi ; Miyoshi, Hiroaki ; Sato, Kensaku ; Yuge, Kotaro ; Ohchi, Takafumi ; Fujino, Shinya ; Shiraiwa, Sachiko ; Katagiri, Mitsuhiro ; Akagi, Yoshito ; Ohshima, Koichi</creator><creatorcontrib>Yoshida, Naohiro ; Kinugasa, Tetsushi ; Miyoshi, Hiroaki ; Sato, Kensaku ; Yuge, Kotaro ; Ohchi, Takafumi ; Fujino, Shinya ; Shiraiwa, Sachiko ; Katagiri, Mitsuhiro ; Akagi, Yoshito ; Ohshima, Koichi</creatorcontrib><description>Background Tumor-infiltrating lymphocytes (TILs), part of the host immune response, have been widely reported as influential factors in the tumor microenvironment for the clinical outcome of colorectal cancer (CRC). However, the network of helper T cells is very complex, and which T-cell subtypes affect the progression of CRC and postoperative prognosis remains unclear. This study investigated the expression of several subtypes of TILs including T helper type 1 (Th1), Th2, Th17, and regulatory T (Treg) cells to determine their correlation with clinicopathologic features and postoperative prognosis. Methods The study investigated the expression of TILs using immunohistochemistry of tissue microarray samples for 199 CRC patients. The number of each T-cell subtype infiltrating tumors was counted using ImageJ software. The relationship between TIL marker expression, clinicopathologic features, and prognosis was analyzed. Results A high RORγT/CD3 ratio (Th17 ratio) was significantly correlated with lymph node metastasis ( p  = 0.002), and a high of Foxp3/CD3 ratio (Treg ratio) was correlated with tumor location in the colon ( p  = 0.04), as shown by the Chi square test. In multivariate analysis, a high RORγT/CD3 ratio was the only independent prognostic factor for overall survival ( p  = 0.04; hazard ratio [HR], 1.84; 95 % confidence interval [CI] 1.02–3.45). Conclusions This study confirmed a high RORγT/CD3 ratio as a strong prognostic marker for postoperative survival. The immunohistochemistry results suggest that Th17 may affect lymph node metastasis in CRC. If new immunotherapies reducing Th17 expression are established, they may improve the efficiency of cancer treatment and prolong the survival of patients with CRC.</description><identifier>ISSN: 1068-9265</identifier><identifier>EISSN: 1534-4681</identifier><identifier>DOI: 10.1245/s10434-015-4923-3</identifier><identifier>PMID: 26564244</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor ; CD3 Complex - metabolism ; CD8-Positive T-Lymphocytes - immunology ; Colorectal Cancer ; Colorectal Neoplasms - immunology ; Colorectal Neoplasms - metabolism ; Colorectal Neoplasms - mortality ; Colorectal Neoplasms - secondary ; Female ; Follow-Up Studies ; Humans ; Immunoenzyme Techniques ; Lymphatic Metastasis ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local - immunology ; Neoplasm Recurrence, Local - metabolism ; Neoplasm Recurrence, Local - mortality ; Neoplasm Recurrence, Local - pathology ; Neoplasm Staging ; Nuclear Receptor Subfamily 1, Group F, Member 3 - metabolism ; Oncology ; Prognosis ; Retrospective Studies ; Surgery ; Surgical Oncology ; Survival Rate ; T-Lymphocytes, Regulatory - immunology ; Th1 Cells - immunology ; Th17 Cells - immunology ; Th2 Cells - immunology ; Tissue Array Analysis</subject><ispartof>Annals of surgical oncology, 2016-03, Vol.23 (3), p.919-927</ispartof><rights>Society of Surgical Oncology 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-7c6781db38d424acaf0e184eee8fbd9eaccac7c5b8eebd3013d026a48461f2883</citedby><cites>FETCH-LOGICAL-c447t-7c6781db38d424acaf0e184eee8fbd9eaccac7c5b8eebd3013d026a48461f2883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1245/s10434-015-4923-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1245/s10434-015-4923-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26564244$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yoshida, Naohiro</creatorcontrib><creatorcontrib>Kinugasa, Tetsushi</creatorcontrib><creatorcontrib>Miyoshi, Hiroaki</creatorcontrib><creatorcontrib>Sato, Kensaku</creatorcontrib><creatorcontrib>Yuge, Kotaro</creatorcontrib><creatorcontrib>Ohchi, Takafumi</creatorcontrib><creatorcontrib>Fujino, Shinya</creatorcontrib><creatorcontrib>Shiraiwa, Sachiko</creatorcontrib><creatorcontrib>Katagiri, Mitsuhiro</creatorcontrib><creatorcontrib>Akagi, Yoshito</creatorcontrib><creatorcontrib>Ohshima, Koichi</creatorcontrib><title>A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells)</title><title>Annals of surgical oncology</title><addtitle>Ann Surg Oncol</addtitle><addtitle>Ann Surg Oncol</addtitle><description>Background Tumor-infiltrating lymphocytes (TILs), part of the host immune response, have been widely reported as influential factors in the tumor microenvironment for the clinical outcome of colorectal cancer (CRC). However, the network of helper T cells is very complex, and which T-cell subtypes affect the progression of CRC and postoperative prognosis remains unclear. This study investigated the expression of several subtypes of TILs including T helper type 1 (Th1), Th2, Th17, and regulatory T (Treg) cells to determine their correlation with clinicopathologic features and postoperative prognosis. Methods The study investigated the expression of TILs using immunohistochemistry of tissue microarray samples for 199 CRC patients. The number of each T-cell subtype infiltrating tumors was counted using ImageJ software. The relationship between TIL marker expression, clinicopathologic features, and prognosis was analyzed. Results A high RORγT/CD3 ratio (Th17 ratio) was significantly correlated with lymph node metastasis ( p  = 0.002), and a high of Foxp3/CD3 ratio (Treg ratio) was correlated with tumor location in the colon ( p  = 0.04), as shown by the Chi square test. In multivariate analysis, a high RORγT/CD3 ratio was the only independent prognostic factor for overall survival ( p  = 0.04; hazard ratio [HR], 1.84; 95 % confidence interval [CI] 1.02–3.45). Conclusions This study confirmed a high RORγT/CD3 ratio as a strong prognostic marker for postoperative survival. The immunohistochemistry results suggest that Th17 may affect lymph node metastasis in CRC. If new immunotherapies reducing Th17 expression are established, they may improve the efficiency of cancer treatment and prolong the survival of patients with CRC.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biomarkers, Tumor</subject><subject>CD3 Complex - metabolism</subject><subject>CD8-Positive T-Lymphocytes - immunology</subject><subject>Colorectal Cancer</subject><subject>Colorectal Neoplasms - immunology</subject><subject>Colorectal Neoplasms - metabolism</subject><subject>Colorectal Neoplasms - mortality</subject><subject>Colorectal Neoplasms - secondary</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Immunoenzyme Techniques</subject><subject>Lymphatic Metastasis</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Recurrence, Local - immunology</subject><subject>Neoplasm Recurrence, Local - metabolism</subject><subject>Neoplasm Recurrence, Local - mortality</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Staging</subject><subject>Nuclear Receptor Subfamily 1, Group F, Member 3 - metabolism</subject><subject>Oncology</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Survival Rate</subject><subject>T-Lymphocytes, Regulatory - immunology</subject><subject>Th1 Cells - immunology</subject><subject>Th17 Cells - immunology</subject><subject>Th2 Cells - immunology</subject><subject>Tissue Array Analysis</subject><issn>1068-9265</issn><issn>1534-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1u1DAUhSMEakvLA7BBd9lKhPovicNuFCiDNFKraVhbjnOTSZWJBzsZKc_FmlfgmfBopixRF_7RyXeO7Zwoek_JJ8pEcuspEVzEhCaxyBmP-avogiZBEamkr8OepDLOWZqcR2-9fyKEZpwkZ9F5kFLBhLiIfi9g2bUbWN-v__wqb4svHNZ67Cx0HjQ8js4OLTw42w7Wj52BO21G66AJ4yEodocu4HuEx8ntu73uoRtgUe_1YLCGwvbWoRmDXBwU9xkWg-5nH9JtA0vsgx9KKLDvYTVvdxtr5hE9XJcb-hHKDTtMNAM91LDGdup1OH0-OfzNVfSm0b3Hd6f1Mvpx97UslvHq_tv3YrGKjRDZGGcmzSStKy7r8GptdEOQSoGIsqnqHLUx2mQmqSRiVXNCeU1YqoUUKW2YlPwyuj7m7pz9OaEf1bbzJlxBD2gnr2iWccmJSNgL0FRwnuciCSg9osZZ7x02aue6rXazokQdClbHglUoWB0KVjx4Ppzip2qL9T_Hc6MBYEfAh09Di0492cmFn-7_k_oX5cCxOw</recordid><startdate>20160301</startdate><enddate>20160301</enddate><creator>Yoshida, Naohiro</creator><creator>Kinugasa, Tetsushi</creator><creator>Miyoshi, Hiroaki</creator><creator>Sato, Kensaku</creator><creator>Yuge, Kotaro</creator><creator>Ohchi, Takafumi</creator><creator>Fujino, Shinya</creator><creator>Shiraiwa, Sachiko</creator><creator>Katagiri, Mitsuhiro</creator><creator>Akagi, Yoshito</creator><creator>Ohshima, Koichi</creator><general>Springer International Publishing</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20160301</creationdate><title>A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells)</title><author>Yoshida, Naohiro ; Kinugasa, Tetsushi ; Miyoshi, Hiroaki ; Sato, Kensaku ; Yuge, Kotaro ; Ohchi, Takafumi ; Fujino, Shinya ; Shiraiwa, Sachiko ; Katagiri, Mitsuhiro ; Akagi, Yoshito ; Ohshima, Koichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-7c6781db38d424acaf0e184eee8fbd9eaccac7c5b8eebd3013d026a48461f2883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biomarkers, Tumor</topic><topic>CD3 Complex - metabolism</topic><topic>CD8-Positive T-Lymphocytes - immunology</topic><topic>Colorectal Cancer</topic><topic>Colorectal Neoplasms - immunology</topic><topic>Colorectal Neoplasms - metabolism</topic><topic>Colorectal Neoplasms - mortality</topic><topic>Colorectal Neoplasms - secondary</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Immunoenzyme Techniques</topic><topic>Lymphatic Metastasis</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Recurrence, Local - immunology</topic><topic>Neoplasm Recurrence, Local - metabolism</topic><topic>Neoplasm Recurrence, Local - mortality</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Staging</topic><topic>Nuclear Receptor Subfamily 1, Group F, Member 3 - metabolism</topic><topic>Oncology</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Survival Rate</topic><topic>T-Lymphocytes, Regulatory - immunology</topic><topic>Th1 Cells - immunology</topic><topic>Th17 Cells - immunology</topic><topic>Th2 Cells - immunology</topic><topic>Tissue Array Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yoshida, Naohiro</creatorcontrib><creatorcontrib>Kinugasa, Tetsushi</creatorcontrib><creatorcontrib>Miyoshi, Hiroaki</creatorcontrib><creatorcontrib>Sato, Kensaku</creatorcontrib><creatorcontrib>Yuge, Kotaro</creatorcontrib><creatorcontrib>Ohchi, Takafumi</creatorcontrib><creatorcontrib>Fujino, Shinya</creatorcontrib><creatorcontrib>Shiraiwa, Sachiko</creatorcontrib><creatorcontrib>Katagiri, Mitsuhiro</creatorcontrib><creatorcontrib>Akagi, Yoshito</creatorcontrib><creatorcontrib>Ohshima, Koichi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Annals of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yoshida, Naohiro</au><au>Kinugasa, Tetsushi</au><au>Miyoshi, Hiroaki</au><au>Sato, Kensaku</au><au>Yuge, Kotaro</au><au>Ohchi, Takafumi</au><au>Fujino, Shinya</au><au>Shiraiwa, Sachiko</au><au>Katagiri, Mitsuhiro</au><au>Akagi, Yoshito</au><au>Ohshima, Koichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells)</atitle><jtitle>Annals of surgical oncology</jtitle><stitle>Ann Surg Oncol</stitle><addtitle>Ann Surg Oncol</addtitle><date>2016-03-01</date><risdate>2016</risdate><volume>23</volume><issue>3</issue><spage>919</spage><epage>927</epage><pages>919-927</pages><issn>1068-9265</issn><eissn>1534-4681</eissn><abstract>Background Tumor-infiltrating lymphocytes (TILs), part of the host immune response, have been widely reported as influential factors in the tumor microenvironment for the clinical outcome of colorectal cancer (CRC). However, the network of helper T cells is very complex, and which T-cell subtypes affect the progression of CRC and postoperative prognosis remains unclear. This study investigated the expression of several subtypes of TILs including T helper type 1 (Th1), Th2, Th17, and regulatory T (Treg) cells to determine their correlation with clinicopathologic features and postoperative prognosis. Methods The study investigated the expression of TILs using immunohistochemistry of tissue microarray samples for 199 CRC patients. The number of each T-cell subtype infiltrating tumors was counted using ImageJ software. The relationship between TIL marker expression, clinicopathologic features, and prognosis was analyzed. Results A high RORγT/CD3 ratio (Th17 ratio) was significantly correlated with lymph node metastasis ( p  = 0.002), and a high of Foxp3/CD3 ratio (Treg ratio) was correlated with tumor location in the colon ( p  = 0.04), as shown by the Chi square test. In multivariate analysis, a high RORγT/CD3 ratio was the only independent prognostic factor for overall survival ( p  = 0.04; hazard ratio [HR], 1.84; 95 % confidence interval [CI] 1.02–3.45). Conclusions This study confirmed a high RORγT/CD3 ratio as a strong prognostic marker for postoperative survival. The immunohistochemistry results suggest that Th17 may affect lymph node metastasis in CRC. If new immunotherapies reducing Th17 expression are established, they may improve the efficiency of cancer treatment and prolong the survival of patients with CRC.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>26564244</pmid><doi>10.1245/s10434-015-4923-3</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1068-9265
ispartof Annals of surgical oncology, 2016-03, Vol.23 (3), p.919-927
issn 1068-9265
1534-4681
language eng
recordid cdi_proquest_miscellaneous_1773830452
source MEDLINE; SpringerNature Journals
subjects Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
CD3 Complex - metabolism
CD8-Positive T-Lymphocytes - immunology
Colorectal Cancer
Colorectal Neoplasms - immunology
Colorectal Neoplasms - metabolism
Colorectal Neoplasms - mortality
Colorectal Neoplasms - secondary
Female
Follow-Up Studies
Humans
Immunoenzyme Techniques
Lymphatic Metastasis
Male
Medicine
Medicine & Public Health
Middle Aged
Neoplasm Invasiveness
Neoplasm Recurrence, Local - immunology
Neoplasm Recurrence, Local - metabolism
Neoplasm Recurrence, Local - mortality
Neoplasm Recurrence, Local - pathology
Neoplasm Staging
Nuclear Receptor Subfamily 1, Group F, Member 3 - metabolism
Oncology
Prognosis
Retrospective Studies
Surgery
Surgical Oncology
Survival Rate
T-Lymphocytes, Regulatory - immunology
Th1 Cells - immunology
Th17 Cells - immunology
Th2 Cells - immunology
Tissue Array Analysis
title A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T18%3A29%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20High%20ROR%CE%B3T/CD3%20Ratio%20is%20a%20Strong%20Prognostic%20Factor%20for%20Postoperative%20Survival%20in%20Advanced%20Colorectal%20Cancer:%20Analysis%20of%20Helper%20T%20Cell%20Lymphocytes%20(Th1,%20Th2,%20Th17%20and%20Regulatory%20T%20Cells)&rft.jtitle=Annals%20of%20surgical%20oncology&rft.au=Yoshida,%20Naohiro&rft.date=2016-03-01&rft.volume=23&rft.issue=3&rft.spage=919&rft.epage=927&rft.pages=919-927&rft.issn=1068-9265&rft.eissn=1534-4681&rft_id=info:doi/10.1245/s10434-015-4923-3&rft_dat=%3Cproquest_cross%3E1764339945%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1764339945&rft_id=info:pmid/26564244&rfr_iscdi=true